The off-label use of targeted therapies in sarcomas: the OUTC’S program

BACKGROUND: Few targeted therapies (TTs) are registered for sarcoma treatment despite numerous phase II studies and yet there are potential treatment options for patients after standard treatment escape. The French Sarcoma Group - Bone Tumor Study Group (GSF-GETO) created a national registry to eval...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cancer
Päätekijät: Eberst, Lauriane, Cropet, Claire, Le Cesne, Axel, Pautier, Patricia, Penel, Nicolas, Adenis, Antoine, Chevreau, Christine, Bay, Jacques-Olivier, Collard, Olivier, Cupissol, Didier, Duffaud, Florence, Gentet, Jean-Claude, Piperno-Neumann, Sophie, Marec-Berard, Perrine, Bompas, Emmanuelle, Thyss, Antoine, Chaigneau, Loic, Cassier, Philippe, Bertucci, François, Blay, Jean-Yves, Ray-Coquard, Isabelle
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2014
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289372/
https://ncbi.nlm.nih.gov/pubmed/25420707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-870
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia